DV
Dividend Vision

DHBUF Stock — Delivra Health Brands Inc

Delivra Health Brands Inc (DHBUF)

Updated October 15, 2026.

DHBUF is a Stock. Total return is -99.1% over the past 9.5 years, 373.8 points behind SPY at 274.7%.

Delivra Health Brands Inc. is a health and wellness consumer packaged goods company that develops and sells sleep aids, pain relief products, and related wellness items under brands including Dream Water and LivRelief, operating globally from its headquarters in Vancouver, Canada. The company does not currently have an established distribution schedule. This security may appeal to investors seeking exposure to the consumer health and wellness sector, though it does not provide regular dividend income.

DHBUF performance versus SPY

Price and return data through 2026-10-15.

Total return is -99.1% over the past 9.5 years, 373.8 points behind SPY at 274.7%. Over the past year its total return — price change plus distributions reinvested — is -60.0%. Its deepest 1-year drawdown was 83.3%.

WindowTotal returnCAGR
1M-20.1%—
3M-24.6%—
6M-51.8%—
YTD-59.2%—
1Y-60.0%—
2Y CAGR—-40.30%
3Y CAGR—-23.70%
5Y CAGR—-35.90%
Since inception (9.5 years)-99.1%-39.00%

DHBUF key facts

Asset type
Stock
Asset class
Equity
Inception date
05/02/2017
Distribution frequency
None
Last close
$0.06 (as of 2026-10-15)
Market cap
$2,025,763
Average volume
10010.0
Beta
0.882
Payout ratio
0.0%
Forward P/E
3.6219
EPS
$-0.02

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

DHBUF risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 83.3%.

Who may consider DHBUF — and who may not

It is a weaker fit for investors who need monthly cash flow (DHBUF does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on DHBUF

Tagged: Healthcare.

Frequently asked questions

Does DHBUF pay monthly?

No. DHBUF does not currently distribute.

When does DHBUF pay a dividend?

DHBUF does not currently distribute.

How has DHBUF performed?

Total return is -99.1% over the past 9.5 years, 373.8 points behind SPY at 274.7%. Over the past year its total return — price change plus distributions reinvested — is -60.0%. Its deepest 1-year drawdown was 83.3%.

DividendVision analysis is generated from public SEC filing data and may not capture every change. Review the original filing for complete information.